The Current Ratio as of December 2025 (TTM) for Synmosa Biopharma Corporation (4114.TWO) is 2.70

According to Synmosa Biopharma Corporation’s latest financial reports and current stock price. The company's current Current Ratio is 2.70. This represents a change of 7.80% compared to the average of 2.50 of the last 4 quarters.

Synmosa Biopharma Corporation (4114.TWO) Historical Current Ratio (quarterly & annually)

How has 4114.TWO Current Ratio performed in the past?

The mean historical Current Ratio of Synmosa Biopharma Corporation over the last ten years is 1.82. The current 2.70 Current Ratio has changed 14.77% with respect to the historical average. Over the past ten years (40 quarters), 4114.TWO's Current Ratio was at its highest in in the June 2025 quarter at 2.70. The Current Ratio was at its lowest in in the December 2022 quarter at 0.

Synmosa Biopharma Corporation (4114.TWO) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Synmosa Biopharma Corporation Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Synmosa Biopharma Corporation (4114.TWO) Average Current Ratio

How has 4114.TWO Current Ratio performed in the past?

The current Current Ratio of Synmosa Biopharma Corporation (4114.TWO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Synmosa Biopharma Corporation (4114.TWO) Current Ratio vs. Peers

How is 4114.TWO’s Current Ratio compared to its peers?

Synmosa Biopharma Corporation’s Current Ratio is greater than Grape King Bio Ltd (1.47), less than Handa Pharmaceuticals, Inc. (9.17), greater than YungShin Global Holding Corporation (2.56), greater than TTY Biopharm Company Limited (1.77), greater than Great Tree Pharmacy Co., Ltd. (1.28), less than Alar Pharmaceuticals Inc. (32.17), less than ScinoPharm Taiwan, Ltd. (5.34), greater than Excelsior Medical Co., Ltd. (1.55), less than Foresee Pharmaceuticals Co., Ltd. (2.92), greater than Standard Chem & Pharm Co. Ltd. (2.07),

Build a custom stock screener for Synmosa Biopharma Corporation (4114.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Synmosa Biopharma Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Synmosa Biopharma Corporation (4114.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Synmosa Biopharma Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.